Skip to main content

Yokogawa establishes innovation center in Allschwil

| News

Yokogawa establishes innovation center in Allschwil

31.07.2020

The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.

Yokogawa Innovation Switzerland GmbH is to start business operations in August, as detailed by a press release issued by Yokogawa Electric Corporation. The establishment of the new Swiss subsidiary in Allschwil has come about thanks to the support offered by Basel Area Business & Innovation, the investment and innovation promotion agency. This organization is responsible for operating the Switzerland Innovation Park Basel Area, where Yokogawa is using office and lab space. Yokogawa also opted for Allschwill due to its proximity to Basel, the “European center of the biotechnology and life science industry”, which it describes as an “ideal location”.

In Allschwil, Yokogawa will seek to drive forward innovations in the field of biotechnology. The market for bio-based products is set to continually expand, and for this reason Yokogawa is keen to exploit the expertise and personnel resources on offer in the Basel region in order to “explore new business opportunities, and forge alliances with other entities that have world-leading technologies”, the press release states. In addition, existing activities in the field of industrial automation based in Switzerland will now also be integrated within the new location.

In terms of the future research and development activities in Allschwil, Yokogawa is planning to benefit from Switzerland’s highly competitive position and skilled workforce. Both of these aspects should ensure that Yokogawa is in a position to comply with the Sustainable Development Goals (SDGs) of the United Nations and contribute to the circular economy.

(Read more about starting a business in Switzerland)

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.